Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study

European Journal of Echocardiography

Volumn 8, Issue 6, 2007, Pages 480-486

  Symeonides, Phivos ^a   Koulouris, Spyridon ^b   Vratsista, Ekaterini ^b   Triantafyllou, Konstantinos ^b   Ioannidis, Georgios ^b   Thalassinos, Nikolaos ^b   Katritsis, Demosthenes ^a  

^a Athens Euroclinic   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Diabetic cardiomyopathy; Renin angiotensin system blockade

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INSULIN; RAMIPRIL; TELMISARTAN;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC CARDIOMYOPATHY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLOW RATE; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; MITRAL VALVE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; BLOOD FLOW VELOCITY; CARDIOMYOPATHIES; CROSS-OVER STUDIES; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RAMIPRIL; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 35449006595     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.09.005     Document Type: Article

References (41)

1. Semeniuk L.M., Kryski A.J., and Severson D.L. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT 4 mice. Am J Physiol Heart Circ Physiol 283 (2002) H976-H982
2. Ganguly P.K., Thliveris J.A., and Mehta A. Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Metabolism 39 (1990) 769-773
3. Park J.W., Ziegler A.G., Janka H.U., Doering W., and Mehnert H. Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study. Klin Wochenschr 66 (1988) 773-778
4. Zarich S.W., Arbuckle B.E., Cohen L.R., Roberts M., and Nesto R.W. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 12 (1988) 114-120
5. Airaksinen J., Ikaheimo M., Kaila J., Linnaluoto M., and Takkunen J. Impaired left ventricular filling in young female diabetics. An echocardiographic study. Acta Med Scand 216 (1984) 509-516
6. Cerutti F., Vigo A., Sacchetti C., Bessone A., Barratia G., Morello M., et al. Evaluation of left ventricular diastolic function in insulin dependent diabetic children by M-Mode and Doppler echocardiography. Panminerva Med 36 (1994) 109-114
7. Schannwell C.M., Schneppenheim M., Perings S., Plehn G., and Strauer B.E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98 1-2 (2002) 33-39
8. Fiorini G., Scotti L.A., Parmigianni M.L., Ferrari M., Pezzoli P., and Bignotti G. An echocardiographic study of left ventricular diastolic function in patients with diabetes mellitus type 2. G Ital Cardiol 25 1 (Jan 1995) 17-25
9. Ferguson R.K., Vlasses P.H., and Rotmensch H.H. Clinical applications of angiotensin converting enzyme inhibitors. Am J Med 77 (1984) 690-698
10. Dahlof B., Pennert K., and Hannson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 5 (1992) 95-110
11. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
12. Mancini G.B., Henry G.C., Macaya C., O'Neill B.J., Pucillo A.L., Carere R.G., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 94 (1996) 258-265
13. Iimura O., Shimamoto K., Matsuda K., Masuda A., Takizawa H., Higashiura K., et al. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 8 (1995) 353-357
14. Weir M., and Dzau V. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 12 (1999) 205S-213S
15. Sahn D.J., De Maria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
16. Rakowski H., Appleton C., Chan K.L., Dumesnil J.G., Honos G., Jue J., et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the investigators of consensus on diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 9 (1996) 736-760
17. Ommen S.R., and Nishimura R.A. A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart 89 (2003) iii18
18. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., and Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30 (1972) 595-602
19. Cosson S., and Kevorkian J.P. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?. Diabetes Metab 29 5 (2003) 455-466
20. Raev D.C. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type 1 diabetic patients. Diabetes Care 17 7 (Jul 1994) 633-639
21. Poirer P., Bogaty P., Garneau C., Marois L., and Dumesnil J. Diastolic dysfunction in normotensive men with well-controlled type 2 Diabetes. Diabetes Care 24 (2001) 5-10
22. Salazar J., Rivas A., Rodriquez M., Felipe J., Garcia M.D., and Bone J. Left ventricular function determined by Doppler echocardiography in adolescents with type 1 (insulin dependent) diabetes mellitus. Acta Cardiol 49 (1994) 435-439
23. Robillon J.F., Sadoul J.L., Jullien D., Morand P., and Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabetes Metab 20 (1994) 473-480
24. Fang Z.Y., Prins J., and Marwick T. Diabetic cardiomyopathy: evidence, mechanisms and therapeutic implications. End rev 25 4 (Aug 2004) 543-567
25. Hayat S., Patel B., Khattar R., and Malik R. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 107 (2004) 539-557
26. Miller J.A., Floras J.S., Zinman B., Skorecki K.L., and Logan A.G. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 90 (1996) 189-195
27. De Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic paptide in cardiovascular disease. Lancet 362 (2003) 316-322
28. Cowie M., and Mendez G. BNP and congestive heart failure. Prog Cardiovasc Dis 44 4 (2002) 293-321
29. Yano Y., Katsuki A., Gabazza E., Ito K., Fujii M., Furuta M., et al. Plasma brain natriuretic peptide levels in normotensive non-insulin dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84 7 (Jul 1999) 2353-2356
30. Lang C.C., Prasad N., McAlpine H.M., MacLeod C., Lipworth B.J., MacDonald T.M., et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 127 (1994) 1635-1636
31. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105 5 (Feb 5 2002) 595-601
32. Valle R., Bagolin E., Canali C., Giovinazzo P., Barro S., Aspromonte N., et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr (May 7 2005)
33. Marcus L.S., Hart D., Packer M., Yushak M., Medina M., Danziger R.S., et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo controlled, randomized crossover trial. Circulation 94 (1996) 3184-3189
34. Kohno M., Minami M., Kano H., Yasunari K., Maeda K., Hanehira T., et al. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating plasma brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism 49 10 (2000) 1356-1360
35. Wachtell K., Bella J.N., Rokkedal J., Palmieri V., Papademetriou V., Dahlof B., et al. Changes in diastolic left ventricular filling after one year of antihypertensive treatment - The LIFE Study. Circulation 105 (2002) 1071
36. Anan F., Takahashi N., Ooie T., Yufu K., Hara M., Nakagawa M., et al. Effects of Valsartan and Perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 61 5-6 (Jul 2005) 353-359
37. Sohn D.W., Chai I.H., Lee D.J., Kim H.C., Oh B.H., Lee M.M., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30 (1997) 474-480
38. Liu J.E., Palmieri V., Roman M.J., Bella J.N., Fabsitz R., Howard B.V., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37 7 (2001 Jun 1) 1943-1949
39. Epshteyn V., Morrison K., Krishnaswamy P., Kazanegra R., Clopton P., Mudaliar S., et al. Utility of B-Type Natriuretic Peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26 (2003) 2081-2087
40. Liu J.E., Robbins D.C., Palmieri V., Bella J.N., Roman M.J., Fabsitz R., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 41 11 (2003 Jun 4) 2022-2028
41. Yamagishi S., and Takeuchi M. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma inducing property. Med Hypotheses 64 3 (2005) 476-478